Newsbenzinga
AbbVie Receives FDA Approval For Its Subcutaneous Induction Regimen For SKYRIZI To Treat Moderately To Severely Active Crohn's Disease
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…